With the COVID-19 virus spreading quickly, IQVIA is working rapidly to mobilise our healthcare information, expertise and data science assets to provide insights on how the healthcare market is adapting. This monthly report studies the specific impact of COVID-19 on the UK pharma and biotech market.
This edition covers:
- Medicines demand and supply insights
- Engagement with healthcare professionals’ insights
- Clinical development and launch environment
- Future healthcare system and pharmaceutical industry environment considerations
A note on data sources: In this report, IQVIA’s data assets will be triangulated with third party sources as well as market events and research.